Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma

Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma

Abstract Background Disulfidptosis is a type of programmed cell death caused by excessive cysteine-induced disulfide bond denaturation leading to actin collapse. Liver cancer has a poor prognosis and requires more effective intervention strategies. Currently, the prognostic and therapeutic value of...

Full description

Bibliographic Details
Main Authors:	Jun Tang, Xintong Peng, Desheng Xiao, Shuang Liu, Yongguang Tao, Long Shu
Format:	Article
Language:	English
Published:	BMC 2024-01-01
Series:	Cancer Cell International
Subjects:	Disulfidptosis Hepatocellular carcinoma Immune microenvironment Prognostic model
Online Access:	https://doi.org/10.1186/s12935-023-03188-y

Similar Items

Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma
by: Zhijian Wang, et al.
Published: (2023-08-01)

Machine learning-based disulfidptosis-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity in hepatocellular carcinoma
by: Lei Pu, et al.
Published: (2024-02-01)

Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma
by: Jiajing Zhao, et al.
Published: (2023-12-01)

Unlocking the future of hepatocellular carcinoma treatment: A comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening
by: Wang Haojun, et al.
Published: (2024-04-01)

Typing and modeling of hepatocellular carcinoma based on disulfidptosis-related amino acid metabolism genes for predicting prognosis and guiding individualized treatment
by: Xuenuo Chen, et al.
Published: (2023-08-01)

Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma
by: Weijie Xue, et al.
Published: (2023-09-01)

Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer
by: Tianzhe Jin, et al.
Published: (2024-06-01)

Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma
by: Lixia Xu, et al.
Published: (2024-01-01)

Development of the RF-GSEA Method for Identifying Disulfidptosis-Related Genes and Application in Hepatocellular Carcinoma
by: Linghao Ni, et al.
Published: (2023-11-01)

Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma
by: Wei Q, et al.
Published: (2023-12-01)

Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies
by: Ti Yang, et al.
Published: (2024-01-01)

Prognosis and chemotherapy drug sensitivity in liver hepatocellular carcinoma through a disulfidptosis-related lncRNA signature
by: Chao Chen, et al.
Published: (2024-03-01)

Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma
by: Di Chen, et al.
Published: (2023-12-01)

Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma
by: Xiao-min Li, et al.
Published: (2023-08-01)

Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration
by: Jiayan Wei, et al.
Published: (2024-02-01)

A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing
by: Zhenyu Liao, et al.
Published: (2023-11-01)

A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma
by: Pengyu Chen, et al.
Published: (2023-09-01)

A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
by: Zipei Song, et al.
Published: (2024-02-01)

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
by: Pan Chen, et al.
Published: (2023-11-01)

Identification and validation of a disulfidptosis-related genes prognostic signature in lung adenocarcinoma
by: Yanpeng Zhang, et al.
Published: (2024-01-01)

Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer
by: Jiahui Liang, et al.
Published: (2023-11-01)

A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
by: Baohui Zhang, et al.
Published: (2020-09-01)

Constructed Risk Prognosis Model Associated with Disulfidptosis lncRNAs in HCC
by: Xiao Jia, et al.
Published: (2023-12-01)

Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis
by: Kai Xu, et al.
Published: (2023-06-01)

Disulfidptosis-related lncRNA signature reveals immune microenvironment and novel molecular subtyping of stomach adenocarcinoma
by: Jinze Li, et al.
Published: (2024-04-01)

Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer
by: Guizhen Pan, et al.
Published: (2024-02-01)

Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis
by: Fangchao Zhao, et al.
Published: (2024-02-01)

A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning
by: Zhitang Wang, et al.
Published: (2023-06-01)

Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer
by: Kuo Kang, et al.
Published: (2023-11-01)

Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
by: Xiaoqing Ma, et al.
Published: (2023-11-01)

Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature
by: Chao Tang, et al.
Published: (2024-03-01)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
by: Yuan Yang, et al.
Published: (2021-06-01)

Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma
by: Yao Zhou, et al.
Published: (2023-12-01)

Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation
by: Yuzhi Wang, et al.
Published: (2023-09-01)

A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma
by: Fuxing Liu, et al.
Published: (2023-06-01)

Disulfidptosis-related classification patterns and tumor microenvironment characterization in skin cutaneous melanoma
by: Li Yang, et al.
Published: (2023-06-01)

Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients
by: Hualin Chen, et al.
Published: (2023-05-01)

Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy
by: Kangjie Xu, et al.
Published: (2024-01-01)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
by: Cong Chen, et al.
Published: (2022-06-01)

Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer
by: Xiaoqian Dong, et al.
Published: (2023-08-01)